1. Home
  2. CDT vs RTC Comparison

CDT vs RTC Comparison

Compare CDT & RTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • RTC
  • Stock Information
  • Founded
  • CDT 2019
  • RTC 2003
  • Country
  • CDT United States
  • RTC China
  • Employees
  • CDT N/A
  • RTC N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • RTC Specialty Chemicals
  • Sector
  • CDT Health Care
  • RTC Industrials
  • Exchange
  • CDT Nasdaq
  • RTC Nasdaq
  • Market Cap
  • CDT 5.3M
  • RTC 6.1M
  • IPO Year
  • CDT N/A
  • RTC N/A
  • Fundamental
  • Price
  • CDT $0.39
  • RTC $0.31
  • Analyst Decision
  • CDT
  • RTC
  • Analyst Count
  • CDT 0
  • RTC 0
  • Target Price
  • CDT N/A
  • RTC N/A
  • AVG Volume (30 Days)
  • CDT 768.1K
  • RTC 24.8M
  • Earning Date
  • CDT 05-15-2025
  • RTC 05-27-2025
  • Dividend Yield
  • CDT N/A
  • RTC N/A
  • EPS Growth
  • CDT N/A
  • RTC N/A
  • EPS
  • CDT N/A
  • RTC N/A
  • Revenue
  • CDT N/A
  • RTC $54,533,127.00
  • Revenue This Year
  • CDT N/A
  • RTC N/A
  • Revenue Next Year
  • CDT N/A
  • RTC N/A
  • P/E Ratio
  • CDT N/A
  • RTC N/A
  • Revenue Growth
  • CDT N/A
  • RTC N/A
  • 52 Week Low
  • CDT $0.51
  • RTC $0.16
  • 52 Week High
  • CDT $350.00
  • RTC $9.69
  • Technical
  • Relative Strength Index (RSI)
  • CDT 31.63
  • RTC 34.48
  • Support Level
  • CDT $0.38
  • RTC $0.29
  • Resistance Level
  • CDT $0.41
  • RTC $0.35
  • Average True Range (ATR)
  • CDT 0.04
  • RTC 0.06
  • MACD
  • CDT 0.01
  • RTC -0.00
  • Stochastic Oscillator
  • CDT 9.89
  • RTC 6.43

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About RTC Baijiayun Group Ltd.

Baijiayun Group Ltd is a ToB video cloud technology service provider that solves various pain points and needs in the field of video technology applications for enterprises. The group supplies energy for the digital development of enterprises through audio and video technology. The firm provides video technology solutions to enterprises and government agencies in various fields such as automobiles, finance, education, and medical care. Baijiayun has created three categories of product services namely video SaaS/PaaS business, video cloud products and software, and video system solutions. It has set up multiple R&D centers, branches, and offices across the country, enabling video technology to create industrial value and promote the development of the real economy.

Share on Social Networks: